Anterogen.Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 46.08%

Anterogen.Co.Ltd (065660) has an Asset Resilience Ratio of 46.08% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 065660 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

₩42.13 Billion

≈ $28.55 Million USD Cash + Short-term Investments

Total Assets

₩91.44 Billion

≈ $61.97 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Anterogen.Co.Ltd's Asset Resilience Ratio has changed over time. See what is Anterogen.Co.Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Anterogen.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Anterogen.Co.Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩42.13 Billion	46.08%
Total Liquid Assets	₩42.13 Billion	46.08%

Asset Resilience Insights

Very High Liquidity: Anterogen.Co.Ltd maintains exceptional liquid asset reserves at 46.08% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Anterogen.Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Anterogen.Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Theragen Etex Co.Ltd KQ:066700	Pharmaceuticals	1.52%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%

Annual Asset Resilience Ratio for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Anterogen.Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	32.88%	₩38.17 Billion ≈ $25.87 Million	₩116.08 Billion ≈ $78.66 Million	+0.13pp
2023-12-31	32.75%	₩48.95 Billion ≈ $33.17 Million	₩149.43 Billion ≈ $101.27 Million	-12.33pp
2022-12-31	45.09%	₩55.97 Billion ≈ $37.93 Million	₩124.13 Billion ≈ $84.12 Million	+1.92pp
2021-12-31	43.17%	₩59.01 Billion ≈ $39.99 Million	₩136.70 Billion ≈ $92.64 Million	-7.70pp
2020-12-31	50.87%	₩47.92 Billion ≈ $32.47 Million	₩94.20 Billion ≈ $63.84 Million	-8.27pp
2019-12-31	59.14%	₩50.03 Billion ≈ $33.90 Million	₩84.59 Billion ≈ $57.33 Million	+9.02pp
2018-12-31	50.12%	₩50.84 Billion ≈ $34.45 Million	₩101.44 Billion ≈ $68.75 Million	+8.19pp
2017-12-31	41.93%	₩24.37 Billion ≈ $16.52 Million	₩58.14 Billion ≈ $39.40 Million	-23.30pp
2016-12-31	65.22%	₩23.11 Billion ≈ $15.66 Million	₩35.43 Billion ≈ $24.01 Million	+24.66pp
2015-12-31	40.57%	₩7.50 Billion ≈ $5.08 Million	₩18.49 Billion ≈ $12.53 Million	-7.13pp
2014-12-31	47.70%	₩6.90 Billion ≈ $4.68 Million	₩14.47 Billion ≈ $9.80 Million	--

pp = percentage points

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$194.04 Million

₩286.33 Billion KRW

Market Cap Rank

#16652 Global

#717 in Korea

Share Price

₩36000.00

Change (1 day)

-4.26%

52-Week Range

₩19850.00 - ₩58000.00

All Time High

₩197700.00